AUGTYROTM (repotrectinib) is indicated for the treatment of adult patients with locally advanced or metastatic ROS1-positive non-small cell lung cancer (NSCLC).
REQUEST A REP
Bristol Myers Squibb is dedicated to providing resources that are useful to both you and your patients from the first dose forward
RESOURCES FOR HEALTHCARE PROVIDERS
AUGTYRO U.S. Full Prescribing Information
Responding to your needs in 24 hours or less
As a leader in immuno-oncology, Bristol Myers Squibb remains committed to helping you and your patients throughout treatment. Call 1-877-AUGTYRO (1-877-284-8976) for live support & assistance, 8:00 AM to 8:00 PM ET, Monday–Friday.
Request a meeting with a representative
Call 1-877-AUGTYRO (1-877-284-8976) to start the process. The initial phone call and any emails that may follow are to schedule a live appointment only. Your representative will discuss product information and answer your questions in person during the scheduled visit.
Medical inquiries and reporting
Visit BMSmedinfo.com or call 1-800-721-5072. Report side effects to the FDA at 1-800-332-1088.
We’re here to help. If you have any additional questions, please call 1-877-AUGTYRO (1-877-284-8976).
RESOURCES FOR YOUR PATIENTS
A complimentary program offering support throughout a patient’s journey